Pfizer, Inc. (PFE) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pfizer, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.739 Good day, everyone, and welcome to Pfizer's first quarter 2025 earnings conference call. 00:00:05.739 -- 00:00:08.242 Today's call is being recorded. 00:00:08.242 -- 00:00:13.029 At this time, I would like to turn the call over to Francesca DiMartino, Chief Investment 00:00:13.029 -- 00:00:16.253 Relations Officer and Senior Vice President. 00:00:16.253 -- 00:00:18.934 Please go ahead, ma'am. 00:00:19.177 -- 00:00:22.201 Good morning, and welcome to Pfizer's earnings call. 00:00:22.201 -- 00:00:25.766 I'm Francesca DiMartino, Chief Investor Relations Officer. 00:00:25.766 -- 00:00:28.837 On behalf of the Pfizer team, thank you for joining us. 00:00:28.837 -- 00:00:33.561 This call is being made available via audio webcast at Pfizer.com. 00:00:33.561 -- 00:00:38.426 Earlier this morning, we released our results for the first quarter of 2025 via a press 00:00:38.426 -- 00:00:42.369 release that is available on our website at Pfizer.com. 00:00:42.369 -- 00:00:48.335 I'm joined today by Dr. Albert Bourla, our chairman and CEO, and Dave Denton, our CFO. 00:00:48.335 -- 00:00:52.919 Albert and Dave have some prepared remarks, and we will then open the call for questions. 00:00:52.919 -- 00:00:57.203 Members of our leadership team will also be available for the Q&A sessions. 00:00:57.203 -- 00:01:01.307 Before we get started, I want to remind you that we will be making forward-looking statements 00:01:01.307 -- 00:01:05.071 and discussing certain non-GAAP financial measures. 00:01:05.071 -- 00:01:08.815 I encourage you to read the disclaimers in our slide presentation, the press release 00:01:08.815 -- 00:01:13.259 we issued this morning, and the disclosures in our SEC filings, which are all available 00:01:13.259 -- 00:01:16.162 on the I...